Nigro J - Search Results

1

Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions.

Little PJ, Osman N, de Dios ST, Cemerlang N, Ballinger M, Nigro J. Little PJ, et al. Among authors: nigro j. Cardiovasc Diabetol. 2007 Oct 28;6:33. doi: 10.1186/1475-2840-6-33. Cardiovasc Diabetol. 2007. PMID: 17963526 Free PMC article.

2

Differential effects of gemfibrozil on migration, proliferation and proteoglycan production in human vascular smooth muscle cells.

Nigro J, Dilley RJ, Little PJ. Nigro J, et al. Atherosclerosis. 2002 May;162(1):119-29. doi: 10.1016/s0021-9150(01)00704-3. Atherosclerosis. 2002. PMID: 11947905

3

High glucose potentiates mitogenic responses of cultured ovine coronary smooth muscle cells to platelet derived growth factor and transforming growth factor-beta1.

Little PJ, Allen TJ, Hashimura K, Nigro J, Farrelly CA, Dilley RJ. Little PJ, et al. Among authors: nigro j. Diabetes Res Clin Pract. 2003 Feb;59(2):93-101. doi: 10.1016/s0168-8227(02)00201-2. Diabetes Res Clin Pract. 2003. PMID: 12560158

4

Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells.

Ballinger ML, Thomas MC, Nigro J, Ivey ME, Dilley RJ, Little PJ. Ballinger ML, et al. Among authors: nigro j. Kidney Int. 2005 Dec;68(6):2756-65. doi: 10.1111/j.1523-1755.2005.00746.x. Kidney Int. 2005. PMID: 16316350 Free article.

5

Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents.

de Dios ST, Frontanilla KV, Nigro J, Ballinger ML, Ivey ME, Cawson EA, Little PJ. de Dios ST, et al. Among authors: nigro j. J Diabetes Complications. 2007 Mar-Apr;21(2):108-17. doi: 10.1016/j.jdiacomp.2006.03.003. J Diabetes Complications. 2007. PMID: 17331859

6

Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesis.

Little PJ, Ballinger ML, Survase S, Osman N, Ogru E, Geytenbeek S, Bruemmer D, Nigro J. Little PJ, et al. Among authors: nigro j. J Cardiovasc Pharmacol. 2008 Mar;51(3):274-9. doi: 10.1097/FJC.0b013e3181626ce7. J Cardiovasc Pharmacol. 2008. PMID: 18356692

7

Fenofibrate modifies human vascular smooth muscle proteoglycans and reduces lipoprotein binding.

Nigro J, Ballinger ML, Dilley RJ, Jennings GL, Wight TN, Little PJ. Nigro J, et al. Diabetologia. 2004 Dec;47(12):2105-13. doi: 10.1007/s00125-004-1588-z. Epub 2004 Dec 9. Diabetologia. 2004. PMID: 15592811

8

Androgens stimulate human vascular smooth muscle cell proteoglycan biosynthesis and increase lipoprotein binding.

Hashimura K, Sudhir K, Nigro J, Ling S, Williams MR, Komesaroff PA, Little PJ. Hashimura K, et al. Among authors: nigro j. Endocrinology. 2005 Apr;146(4):2085-90. doi: 10.1210/en.2004-1242. Epub 2005 Jan 20. Endocrinology. 2005. PMID: 15661861

9

New approaches to regulating the chondroitin/dermatan sulfate glycosaminoglycan component of the vascular extracellular matrix.

Nigro J, Ballinger ML, Survase S, Osman N, Little PJ. Nigro J, et al. ScientificWorldJournal. 2005 Jul 12;5:515-20. doi: 10.1100/tsw.2005.69. ScientificWorldJournal. 2005. PMID: 16075147 Free PMC article. Review. No abstract available.

10

Insulin resistance and atherosclerosis.

Nigro J, Osman N, Dart AM, Little PJ. Nigro J, et al. Endocr Rev. 2006 May;27(3):242-59. doi: 10.1210/er.2005-0007. Epub 2006 Feb 21. Endocr Rev. 2006. PMID: 16492903 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters